ロード中...
The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial
INTRODUCTION: Breast cancer represents about one-third of all cancer diagnoses and accounts for about 15% of cancer deaths in women. Many of these patients experience depression, anxiety, sleep disturbances and cognitive dysfunction. This may adversely affect quality of life and also contribute to m...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3278491/ https://ncbi.nlm.nih.gov/pubmed/22240653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2011-000647 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|